OncXerna Therapeutics Funding: $97M Raised, Series B (2019)
OncXerna Therapeutics is based in Waltham, MA. It has raised $97M in total funding. Latest round: Series B.
OncXerna Therapeutics funding overview
OncXerna Therapeutics is based in Waltham, MA. OncXerna Therapeutics has raised $97M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2019. The round record for OncXerna Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include NAN Fung Life Sciences, Peter Bisgaard, Avalon Ventures, Domain Associates, OrbiMed, Osage University Partners and 7 others. 13 distinct backers are named across the disclosed rounds.
OncXerna Therapeutics at a glance
Total raised
$97M
Latest round
Series B
Latest round date
June 2019
Headquarters
Waltham, MA
Notable investors
NAN Fung Life Sciences, Peter Bisgaard, Avalon Ventures, Domain Associates, OrbiMed, Osage University Partners, Pivotal BioVenture Partners, Rivervest
Frequently asked about OncXerna Therapeutics funding
How much has OncXerna Therapeutics raised?
OncXerna Therapeutics has raised $97M in total disclosed funding across the rounds on record.
Who has invested in OncXerna Therapeutics?
NAN Fung Life Sciences, Peter Bisgaard, Avalon Ventures, Domain Associates, OrbiMed, Osage University Partners are named among the investors backing OncXerna Therapeutics.
What was the latest OncXerna Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2019.
Where is OncXerna Therapeutics based?
OncXerna Therapeutics is based in Waltham, MA.
When did OncXerna Therapeutics last raise?
The last disclosed OncXerna Therapeutics round closed in June 2019 at Series B.
We update the OncXerna Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Waltham and their backers are listed below.
